EXOSC9

protein-coding

exosome component 9, the group of Exosome complex

Gene summary

This gene encodes a component of the human exosome, a exoribonuclease complex which processes and degrades RNA in the nucleus and cytoplasm. This component may play a role in mRNA degradation and the polymyositis/scleroderma autoantigen complex. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]

Previous symbols:
  • PMSCL1

MANE transcript

NM_005033.3

Inheritance

AR

ClinVar variants

P:35U:143B:49

Top phenotype

Pontocerebellar hypoplasia, type 1D

gnomAD constraint

pLI —, LoF o/e 0.76

Max pathogenic AF

—

Genomic locus

chr4:121,801,318-121,817,021

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~15.7 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

pontocerebellar hypoplasia, type 1DSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0054844

Submitter: G2P

pontocerebellar hypoplasia type 1SUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0016396

Submitter: Orphanet

pontocerebellar hypoplasia, type 1DSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0054844

Submitter: Labcorp Genetics (formerly Invitae)

pontocerebellar hypoplasia, type 1DMODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0054844

Submitter: Ambry Genetics

pontocerebellar hypoplasia, type 1DSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0054844

Submitter: PanelApp Australia

Clinical Genomic Database (CGD)

Pontocerebellar hypoplasia, type 1DAR

Manifestation: Craniofacial; Musculoskeletal; Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 29727687; 30690203Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to EXOSC9 variants in ClinVar

10 Conditions Cataloged
not providedTotal: 269
Inborn genetic diseasesTotal: 66
Pontocerebellar hypoplasia, type 1DTotal: 19
EXOSC9-related disorderTotal: 7
not specifiedTotal: 5
Cerebral atrophyTotal: 1
Pontoneocerebellar hypoplasiaTotal: 1
Pontocerebellar atrophyTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_005033.3. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
43
clinvar
3
clinvar
48
missense
2
clinvar
1
clinvar
136
clinvar
2
clinvar
1
clinvar
142
nonsense
5
clinvar
4
clinvar
9
start loss
0
frameshift
13
clinvar
3
clinvar
4
clinvar
20
splice donor/acceptor (+/-2bp)
1
clinvar
6
clinvar
1
clinvar
8
Total2114143454227

Highest pathogenic variant AF is 0.00021460486

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 43 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_005033.3RefSeqNP_005024.212MANE Select
ENST00000243498.10EnsemblENSP00000243498.512MANE Select
NM_001034194.2RefSeqNP_001029366.113Standard
ENST00000379663.7EnsemblENSP00000368984.313Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • RNA degradation - Homo sapiens (human)
  • Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA
  • KSRP (KHSRP) binds and destabilizes mRNA
  • Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
  • Metabolism of RNA

Biological Process

  • exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
  • nuclear-transcribed mRNA catabolic process
  • rRNA processing
  • immune response
  • rRNA catabolic process

Molecular Function

  • 3'-5'-exoribonuclease activity
  • RNA polymerase II activating transcription factor binding
  • RNA binding
  • exoribonuclease activity
  • protein binding

Cellular Component

  • nuclear exosome (RNase complex)
  • cytoplasmic exosome (RNase complex)
  • exosome (RNase complex)
  • nuclear chromosome
  • nucleus

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000379663
Coding exons
13
Length
15705
Individuals with no LoFs
125600
Homozygous LoFs
0
Heterozygous LoFs
148
Defined
125748
p
0.000589
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.1532342410.9720.00001192987
Missense (PolyPhen)4755.7950.84236694
Synonymous0.1677879.90.9760.00000405854
Loss of Function1.122026.20.7640.00000142313

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000690.00068rare
Latino/Admixed American0.000350.00035rare
Ashkenazi Jewish0.000100.000099rare
East Asian0.000220.00022rare
Finnish0.00130.0013notable
European (Non-Finnish)0.000660.00065rare
South Asian0.000500.00049rare
Other0.000350.00033rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes. EXOSC9 binds to ARE-containing RNAs. {ECO:0000269|PubMed:11782436, ECO:0000269|PubMed:16455498, ECO:0000269|PubMed:16912217, ECO:0000269|PubMed:17545563}.;

Recessive Scores

pRec
0.123

Intolerance Scores

LoFtool
0.978
RVIS EVS
-0.25
RVIS percentile EVS
35.99

Essentials

Essential (CRISPR)
E
Essential (CRISPR2)
E
Essential (gene trap)
E
Indispensability pred.
E
Indispensability score
0.750

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.